The effects of increased glucose level and glycolysis on SARS CoV-2 infection

Basit Öğe Kaydı
dc.authorid0000-0002-1423-0435
dc.contributor.authorZurnacı, Fatma Özlem
dc.contributor.authorGüzel, Mustafa
dc.date.accessioned2022-10-07T10:39:40Z
dc.date.available2022-10-07T10:39:40Z
dc.date.issued2022
dc.departmentİstanbul Medipol Üniversitesi, Rektörlük, Sağlık Bilim ve Teknolojileri Araştırma Enstitüsü
dc.departmentİstanbul Medipol Üniversitesi, Sağlık Bilimleri Enstitüsü, Moleküler Tıp ve Biyoteknoloji Ana Bilim Dalı
dc.departmentİstanbul Medipol Üniversitesi, Uluslararası Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Tıbbi Farmakoloji Ana Bilim Dalı
dc.description.abstractCOVID-19 has entered our lives as an infection with high mortality rates. Although the vaccination process has provided benefits, the death toll remains frightening worldwide. Therefore, drugs and combined therapies that can be used against COVID-19 infection are still being investigat-ed. Most of these antiviral medications are investigational drug candidates that are still in clinical tri-als. In this context, holistic and different approaches for the treatment of COVID-19, including prophylactic use of natural medicines, are under investigation and may offer potential treatment op-tions due to the fact that this is still an unmet medical need of the world. Thus, inhibiting the increased glycolysis in COVID-19 infection with glycolysis inhibitors may be beneficial for patient survival. This short review highlights the potential benefits of glycolysis inhibition as well as controlling the elevated glucose levels in patients with COVID-19.
dc.identifier.citationZurnacı, F. Ö. ve Güzel, M. (2022). The effects of increased glucose level and glycolysis on SARS CoV-2 infection. Mini-Reviews in Medicinal Chemistry, 22(18). https://doi.org/10.2174/1389557522666220318115350
dc.identifier.doi10.2174/1389557522666220318115350
dc.identifier.issn1389-5575
dc.identifier.issn1875-5607
dc.identifier.issue18
dc.identifier.pmid35306995
dc.identifier.scopus2-s2.0-85138400385
dc.identifier.scopusqualityQ2
dc.identifier.urihttps://doi.org/10.2174/1389557522666220318115350
dc.identifier.urihttps://hdl.handle.net/20.500.12511/9812
dc.identifier.volume22
dc.identifier.wos000860470800005en_US
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorZurnacı, Fatma Özlem
dc.institutionauthorGüzel, Mustafa
dc.language.isoen
dc.publisherBentham Science Publishers
dc.relation.ispartofMini-Reviews in Medicinal Chemistryen_US
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAntiviral Research
dc.subjectCOVID-19 Treatment
dc.subjectDiabetes
dc.subjectGlucose Level
dc.subjectGlycolysis Inhibition
dc.subjectSARS-CoV-2
dc.titleThe effects of increased glucose level and glycolysis on SARS CoV-2 infection
dc.typeReview Article

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Diğer Yayınlar Koleksiyonu
Diğer Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Sağlık Bilimleri Enstitüsü Diğer Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu